Harnessing chitosan and poly-(γ-glutamic acid)-based biomaterials towards cancer immunotherapy
Cancer-related immunosuppression is one of the most challenging aspects of cancer therapy, being one of the principal causes of disease relapse. Most recent immunotherapeutic strategies have been at the forefront of therapies to overcome this problem through targeting T cell-related pathways. Notwit...
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Elsevier
2022-08-01
|
| Edice: | Materials Today Advances |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2590049822000480 |